SMI Equal Weight

SMI Equal Weight handeln
378,16 PKT -2,78 PKT -0,73 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH1528602787


Analysen zu SMI Equal Weight-Werten

Datum Rating Analyst
31.01.05 Lonza Reduce Sarasin Research
31.01.05 Novartis Outperform Credit Suisse First Boston
02.02.05 UBS Outperform Credit Suisse First Boston
31.01.05 Nestlé Neutral Sarasin Research
01.02.05 Logitech Kauf SYZ & CO
01.02.05 Roche Neutral Credit Suisse First Boston
31.01.05 Roche Buy Sarasin Research
28.01.05 Holcim Verkaufen Helaba Trust
31.01.05 Novartis Buy Helvea
27.01.05 Holcim Neutral Helvea
03.02.05 Novartis Outperformer Sparkasse KölnBonn
27.01.05 Holcim Halten Helaba Trust
27.01.05 Lonza Buy Helvea
26.01.05 Novartis Market Perform William Blair
26.01.05 Lonza Reduce Sarasin Research
26.01.05 UBS Buy Sarasin Research
25.01.05 Holcim Accumulate Helvea
25.01.05 Novartis Buy Helvea
25.01.05 Lonza Overweight JP Morgan
25.01.05 UBS Buy Helvea
25.01.05 Novartis Halten LB Baden-Württemberg
25.01.05 Swisscom Underweight Lehman Brothers
25.01.05 Novartis Outperform Goldman Sachs
26.01.05 Nestlé Outperform Credit Suisse First Boston
24.01.05 Novartis Overweight Prudential Securities
24.01.05 Holcim Neutral Sarasin Research
25.01.05 Novartis Neutral Sarasin Research
24.01.05 Richemont Outperform Goldman Sachs
24.01.05 Novartis Neutral Sarasin Research
24.01.05 Richemont Neutral Merrill Lynch
24.01.05 Lonza Reduce Sarasin Research
21.01.05 Zurich Insurance Buy Sarasin Research
21.01.05 Roche Buy Sarasin Research
24.01.05 Novartis Neutral HypoVereinsbank
21.01.05 Richemont Buy Sarasin Research
21.01.05 Zurich Insurance Accumulate Helvea
21.01.05 Novartis Kaufen Helaba Trust
21.01.05 Richemont Accumulate Helvea
24.01.05 Novartis Kaufen Hamburger Sparkasse
21.01.05 Richemont Buy Sarasin Research